comparemela.com

Page 4 - Dementia Discovery Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Merck to Acquire Caraway Therapeutics, Inc

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. announced today that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Caraway Therapeutics for a total potential consideration of up to $610 million .

Merck Neuroscience Acquisition Brings a Startup With Parkinson s, ALS Programs

Merck’s acquisition of Caraway Therapeutics adds programs for genetically defined neurodegenerative diseases. One of those programs addresses a target that was the focus of a different startup purchased by Merck in 2019.

Dementia Discovery Fund Announces the Acquisition of Caraway Therapeutics by Merck

Dementia Discovery Fund Announces the Acquisition of Caraway Therapeutics by Merck
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Merck seals $610M deal to acquire preclinical biotech Caraway

Merck seals $610M deal to acquire preclinical biotech Caraway
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Merck & Co , Inc to Acquire Caraway Therapeutics, Inc

Merck & Co , Inc to Acquire Caraway Therapeutics, Inc
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.